ArticleCancer management and research2020

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC.

Naoko Katsurada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.